Nav: Home

Nijmegen breakage syndrome: Molecular pathways that lead to microcephaly

September 08, 2016

Scientists from Jerusalem and Duesseldorf have succeeded in generating induced pluripotent stem cells from a rare disorder called Nijmegen breakage syndrome (NBS) and to push these cells to become early neurons, revealing the mechanisms leading to the neurological phenotype observed in these patients.

Nijmegen breakage syndrome is a devastating disorder in which the affected children suffer from pronounced microcephaly, cognitive impairments, dwarfism, strong cancer predisposition, and immunodeficiency. The syndrome is caused when a child receives a mutant NBS1 gene from both his parents. It was known that the NBS1 gene is important for the recognition of breaks in the DNA of the child, explaining the cancer predisposition and immunodeficiency of the patients. However, it was not clear how this gene affects the development of the brain and why the affected children suffer from smaller brains. Therefore, the generation of induced pluripotent stem cells from patients and the ability to turn them into neurons, as published in the latest issue of the journal Cell Reports, gave scientists the opportunity to study the causes for brain impairment as seen in affected children.

Prof. Michal Goldberg and Prof. Nissim Benvenisty from the Hebrew University of Jerusalem, together with Prof. James Adjaye from the Heinrich Heine University in Duesseldorf, in a study led by graduate student Tomer Halevy, succeeded in generating induced pluripotent stem cells from two patients, a boy and a girl, carrying the syndrome, and looked at different characteristic of the cells. Previous studies to understand the disorder were performed on skin cells, and so the causes for the neural pathologies were unknown.

Surprisingly, in this study, the investigators found that P53, a gene with a well known role in preventing cancer may also be responsible for the neural phenotype of Nijmegen breakage syndrome. P53 was demonstrated to be a target of the NBS1 gene, and an emerging role for P53 in early neural development has been suggested. In this study, the researchers have found that since NBS1 is missing in patients' neurons P53 cannot work properly, this in turn leads to cancer development but also affects the early development of the nervous system.

According to Prof. Goldberg, a researcher from the Department of Genetic at the Hebrew University of Jerusalem and principal co-author of the study "Induced pluripotent stem cells derived from Nijmegen breakage syndrome patients provide a powerful tool to study different aspects of the disease, mainly the neural phenotype, as we are able to turn these cells into neural cells and study the developmental aspects of the disorder that could not have been studied before. We can now zoom in and detect dysregulated molecular pathways in neuron derived from patient cells and understand how they affect the children with the disorder. Furthermore, since many diseases resulting from mutations in genes that are important for genomic stability show apart from cancer predisposition also neurological phenotypes, our findings may serve as a platform for the study of additional genomic stability syndromes and pave the way for elucidating the crosstalk between genomic stability and neurological impairments".

Two great advantages of induced pluripotent cells that carry the disorder have on previously used cells, are their ability to become any cell type that we want to study, and their limitless replication potential. We can thus use these cells to perform drug screenings to test for compounds to correct some of the dysregulated pathways that we discovered to be involved in the development of the syndrome. This will be done in our case on derived neural cells but can be performed on any other cell type depending on the tissue we wish to treat.

The cells that were generated and the mechanism underlying the neural phenotype of Nijmegen breakage syndrome, which was discovered in this work will greatly facilitate in the search for a treatment for affected children and also in our understanding of related disorders associated with problems in DNA breaks recognition that have a similar neural phenotype.

According to Prof. Adjaye, Director of the Institute for stem cell research and regenerative medicine, the established and additional NBS induced pluripotent stem cell lines will serve as useful in vitro models to study the underlying mechanism(s) linking impaired neurogenesis to microcephaly by establishing NBS-derived brain organoids and comparing these to organoids derived from healthy individuals.
The research was supported by the Israel Science Foundation (grant no. 684/13) to M.G., and by the Israel Science Foundation (grant no. 269/12), the Israel Science Foundation-Morasha Foundation (grant number 1252/12), the Rosetrees Trust, and the Azrieli Foundation to N.B. J.A. acknowledges support from the Medical Faculty of the Heinrich Heine University Düsseldorf, Germany

Publication: Tomer Halevy,Shira Akov, Martina Bohndorf, Barbara Mlody, James Adjaye, Nissim Benvenisty and. Michal Goldberg (2016). Chromosomal Instability and Molecular Defects in Induced Pluripotent Stem Cells from Nijmegen Breakage Syndrome Patients. Cell Reports 16, 1-13

Heinrich-Heine University Duesseldorf

Related Neurons Articles:

A molecule that directs neurons
A research team coordinated by the University of Trento studied a mass of brain cells, the habenula, linked to disorders like autism, schizophrenia and depression.
Shaping the social networks of neurons
Identification of a protein complex that attracts or repels nerve cells during development.
With these neurons, extinguishing fear is its own reward
The same neurons responsible for encoding reward also form new memories to suppress fearful ones, according to new research by scientists at The Picower Institute for Learning and Memory at MIT.
How do we get so many different types of neurons in our brain?
SMU (Southern Methodist University) researchers have discovered another layer of complexity in gene expression, which could help explain how we're able to have so many billions of neurons in our brain.
These neurons affect how much you do, or don't, want to eat
University of Arizona researchers have identified a network of neurons that coordinate with other brain regions to influence eating behaviors.
Mood neurons mature during adolescence
Researchers have discovered a mysterious group of neurons in the amygdala -- a key center for emotional processing in the brain -- that stay in an immature, prenatal developmental state throughout childhood.
Connecting neurons in the brain
Leuven researchers uncover new mechanisms of brain development that determine when, where and how strongly distinct brain cells interconnect.
The salt-craving neurons
Pass the potato chips, please! New research discovers neural circuits that regulate craving and satiation for salty tastes.
When neurons are out of shape, antidepressants may not work
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed medication for major depressive disorder (MDD), yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with MDD.
Losing neurons can sometimes not be that bad
Current thinking about Alzheimer's disease is that neuronal cell death in the brain is to blame for the cognitive havoc caused by the disease.
More Neurons News and Neurons Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at